Your browser doesn't support javascript.
loading
Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey, Soumya; Nakagawa, Mayumi; Rosenbaum, Eric R; Arnaoutakis, Konstantinos; Hutchins, Laura F; Makhoul, Issam; Milojkovic, Natasha; Cottler-Fox, Michele.
Afiliación
  • Pandey S; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
J Clin Apher ; 30(1): 50-4, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25042026

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Intercambio Plasmático / Púrpura Trombocitopénica Trombótica / Factor VIII / Proteínas ADAM / Rituximab Límite: Adult / Aged / Female / Humans / Male Idioma: En Revista: J Clin Apher Año: 2015 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Intercambio Plasmático / Púrpura Trombocitopénica Trombótica / Factor VIII / Proteínas ADAM / Rituximab Límite: Adult / Aged / Female / Humans / Male Idioma: En Revista: J Clin Apher Año: 2015 Tipo del documento: Article